SS-31 for laboratory research. Batch-level documentation with CoA. Research use only — not for human use. A synthetic tetrapeptide that selectively targets the inner mitochondrial membrane via cardiolipin binding. In September 2025, elamipretide (SS-31) received accelerated FDA approval for Barth syndrome.
Peptalis — for laboratory research use only. Not for human use.